Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Jun. 30, 2015	Jun. 30, 2014
Operating activities:
Net income (loss)	$ 1,570,791	$ (5,293,919)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Stock-based compensation expense	2,545,324	2,667,969
Amortization of intangible assets	23,657
Depreciation and amortization	322,147	355,320
Accretion and amortization on debt securities	314,425	300,724
Provision (recoveries) for bad debt	8,500	(3,200)
Changes in assets and liabilities:
Accounts receivable	(432,899)	(1,021,778)
Other assets	(444,422)	(169,498)
Accounts payable	351,897	(281,531)
Accrued payroll and related taxes	(118,740)	131,238
Deferred revenue	670,729	1,116,999
Deferred taxes	(634,930)
Other liabilities	13,922	(110,206)
Net cash provided by (used in) operating activities	4,190,401	(2,307,882)
Investing activities:
Purchases of investments	(21,804,733)	(20,691,725)
Sales and maturities of investments	17,956,088	8,933,624
Acquisition, net of cash acquired	(5,433,235)
Purchases of property and equipment	(52,318)	(132,199)
Net cash used in investing activities	(9,334,198)	(11,890,300)
Financing activities:
Proceeds from exercise of stock options	124,626	58,834
Principal payments on capital lease obligations	(15,612)	(13,982)
Net cash provided by financing activities	109,014	44,852
Foreign currency effect on cash and cash equivalents	(981)
Net decrease in cash and cash equivalents	(5,035,764)	(14,153,330)
Cash and cash equivalents at beginning of period	7,766,590	23,294,456
Cash and cash equivalents at end of period	2,730,826	9,141,126
Supplemental disclosures of cash flow information:
Cash paid for interest	3,144	4,773
Cash paid for income taxes	2,897	2,226
Supplemental disclosures of non-cash investing and financing activities:
Settlement of note receivable as consideration for business acquisition	250,000
Unrealized holding (loss) gain on available-for-sale investments	$ (6,271)	897
Cashless settlement of restricted stock units		15
Cashless exercise of stock options		$ 3